All
individuals should be evaluated annually for type 2 diabetes risk on the basis of demographic and clinical criteria. Screening
for diabetes (algorithm, or Figure 1 for flowchart) using an FPG should be
performed every 3 years in individuals
>40 years of age. More frequent and/or
earlier testing with either an FPG or a 2hPG in a 75-g OGTT should be considered in those with additional risk factors.
Age >_40 years
First-degree
relative with diabetes
Member
of high-risk population (eg. People of Aboriginal,
Hispanic, South Asian, Asian or African descent)
History of IGT or IFG*
Presence
of complications associated with diabetes
Vascular disease*
History of GDM
History of delivery of a macrosomic infant
Hypertension*
Dyslipidemia*
Overweight*
Abdominal obesity*
Polycystic ovary syndrome*
Acanthosis nigricans*
Schizophrenia
*associated with the metabolic
syndrome
Clinical identification of the
metabolic syndrome* using NCEP ATPIII criteria
|
Risk Factor |
Defining Level |
|
FPG |
>/= 6.1 mm/L |
|
BP |
>/+ 130/85 |
|
TG |
>/= 1.7 mm/L |
|
HDL-C Men Women |
<1.0 mm/L <1.3 mm/L |
|
Abd. Obesity Men Women |
Waist Circ. >102 cm. >88 cm. |
*A diagnosis of metabolic syndrome is made when 3 or more of
the risk determinants are present.
Canadian Diabetes Association Clinical Practice Guidelines
for the Prevention and Management of Diabetes in Canada. Can J Diabetes. 2003;27(suppl 2): S1-S152.